222 related articles for article (PubMed ID: 15870931)
21. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
Touab M; Arumi-Uría M; Barranco C; Bassols A
Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
[TBL] [Abstract][Full Text] [Related]
22. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
23. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
[TBL] [Abstract][Full Text] [Related]
24. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
Prieto VG; Mourad-Zeidan AA; Melnikova V; Johnson MM; Lopez A; Diwan AH; Lazar AJ; Shen SS; Zhang PS; Reed JA; Gershenwald JE; Raz A; Bar-Eli M
Clin Cancer Res; 2006 Nov; 12(22):6709-15. PubMed ID: 17121890
[TBL] [Abstract][Full Text] [Related]
25. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
26. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
Zhang Y; Huang D; Yu G
Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions.
Vetter CS; Müller-Blech K; Schrama D; Bröcker EB; Becker JC
Arch Dermatol Res; 2005 Jul; 297(1):26-30. PubMed ID: 15906050
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
Besch R; Berking C; Kammerbauer C; Degitz K
Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
[TBL] [Abstract][Full Text] [Related]
29. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
30. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
31. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
Li H; Niederkorn JY; Neelam S; Alizadeh H
Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
[TBL] [Abstract][Full Text] [Related]
33. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
34. WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
Lai FJ; Cheng CL; Chen ST; Wu CH; Hsu LJ; Lee JY; Chao SC; Sheen MC; Shen CL; Chang NS; Sheu HM
Clin Cancer Res; 2005 Aug; 11(16):5769-77. PubMed ID: 16115915
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
Ben Simon GJ; Abulafia A; Pe'er J
Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
[TBL] [Abstract][Full Text] [Related]
36. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
37. Survivin expression and its clinical significance in pancreatic cancer.
Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
[TBL] [Abstract][Full Text] [Related]
38. Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion.
Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2007 Dec; 29(6):566-7. PubMed ID: 18032954
[TBL] [Abstract][Full Text] [Related]
39. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
40. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax.
Temme A; Rodriguez JA; Hendruschk S; Günes S; Weigle B; Schäkel K; Schmitz M; Bachmann M; Schackert G; Rieber EP
Cancer Lett; 2007 Jun; 250(2):177-93. PubMed ID: 17084966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
